Genetic & Genomic Medicine in China: Opportunities and Challenge | Duke Kunshan University
Genetic & Genomic Medicine in China: Opportunities and Challenge
Dr. Ming Qi

Professor & Director, Center for Genetic & Genomic Medicine, Zhejiang University; Chief Scientist, Department of Healthcare, BGI Professor, Department of Pathology & Laboratory Medicine, University of Rochester Medical Center

Nov 11th 2015 12:15 to 13:15
Room 1079, Academic Building
Wednesday, January 17, 2018 - 18:00

Summary of Talk:

Precision medicine is hot topic globally since President Obama brought it up. What is precision medicine? How is it related to Genetic & Genomic Medicine? This seminar intends to cover the following questions:

• What are the impacts of Genetic & Genomic Medicine?

• Is this a promising field for students?

• Could we enjoy the outcome for it yet?

• Should medical professionals learn the new knowledge?

• Any collaboration opportunities for other professionals?

• Should the leaders of universities/research institutes make a strategic move?

• Any investment opportunities?

• Should government take any actions for regulation in this field?


Brief Biography:

Dr. Ming Qi received his B.S. from South China Normal University in 1982. He received his M.S. from Fudan University, Shanghai in 1985 and was mentored by Dr. C.C. Tan, the “Father of Genetics at China”. He succeeded in the national competition to be a student of the CUSBEA (China-USA Biochemistry / Molecular Biology) Program and received his Ph.D. from the University of Pittsburgh in 1991. Dr. Qi did his postdoctoral training in Dr. Stan McKnight’s Lab, University of Washington from 1991-1994. Dr. Qi had his clinical postdoctoral fellowship in Molecular Genetics with Dr. Peter Byers at the University of Washington from 1994-1998 and was certified in clinical molecular genetics by American Board of Medical Genetics in 1999. He is a Fellow of American College of Medical Genetics and Genomics. He has been the faculty of University of Rochester Medical School since 1998. Dr. Qi served as a consultant of Harvard Medical School-Partner Center for Genetics and Genomics and Visiting Geneticist of the Laboratory of Molecular Medicine in 2006.


Dr. Qi returned to China since 2004 for a call from Drs. Huanming Yang, Denian Ba, Jian Wang and Jun Yu, a group well known geneticists and old friends at UW, in order to promote genomics in clinical practices. Dr. Qi established first in China the Genetic and Genomic Clinic at Zhejiang University. He hosted 5 international symposiums of genetic and genomic medicine, inviting Arno Motulsky, Peter Byers, Judi Hall, Francis Collins etc. He is the coordinator of the international Human Variome Project Chinese Consortium.

Most recently Dr. Qi led an international team identified NMNAT1 as a new Leber Congenital Amaurosis disease causing gene by using the latest advanced genomic technology exome sequencing, published in Nature Genetics.